Clinical trial

Chemotherapy and Stem Cell Transplantation in Treating Children With Central…

NCT00053118 · Roswell Park Cancer Institute, Other · Completed

Key facts

NCT number NCT00053118
Title Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer
Official title High Dose Carboplatin Combined With Oral VP-16 In The Treatment Of Pediatric CNS Malignancies
Lead sponsor Roswell Park Cancer Institute, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma
Intervention type Biological, Drug, Procedure
Interventions filgrastim, carboplatin, etoposide, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation
Enrollment 1
Start date Mar 1, 2002
Primary completion Jul 1, 2004
Completion Jul 1, 2004
First posted Jan 28, 2003
Last update posted Mar 1, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies